1 / 18

INHALATIONAL ANESTHETICS PHYSIOLOGICAL EFFECTS AND CLINICAL COMPARISONS

INHALATIONAL ANESTHETICS PHYSIOLOGICAL EFFECTS AND CLINICAL COMPARISONS. DENNIS STEVENS MSN, CRNA, ARNP SEPTEMBER 2006 FLORIDA INTERNATIONAL UNIVERSITY PHARMACOLOGY OF ANESTHESIOLOGY NURSING NGR 6173. OBJECTIVES. Discuss the discovery and early development of inhalational anesthetics.

oriana
Download Presentation

INHALATIONAL ANESTHETICS PHYSIOLOGICAL EFFECTS AND CLINICAL COMPARISONS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. INHALATIONAL ANESTHETICSPHYSIOLOGICAL EFFECTSAND CLINICAL COMPARISONS DENNIS STEVENS MSN, CRNA, ARNP SEPTEMBER 2006 FLORIDA INTERNATIONAL UNIVERSITY PHARMACOLOGY OF ANESTHESIOLOGY NURSING NGR 6173

  2. OBJECTIVES • Discuss the discovery and early development of inhalational anesthetics. • Explain theories of anesthetic action related to inhalational anesthetics. • Define MAC and respective percentages for volatile anesthetic agents. • Compare and contrast the physical properties of inhalational anesthetics and their effects on organ systems. • Discuss biotransformation and contraindications related to specific volatile anesthetic agents.

  3. HISTORY • 1840’S • Nitrous oxide • Diethyl Ether • Chloroform • 1920’s – 1940’s • Ethylene • Cyclopropane • Divinyl Ether • 1950’s • Discoveries in fluorine chemistry

  4. INHALATIONAL AGENTS • Nitrous Oxide (N20) • Halothane (Fluothane) • Enflurane (Ethrane) • Isoflurane (Forane) • Desflurane (Suprane) • Sevoflurane (Ultane)

  5. CHEMICAL STRUCTURE OFINHALATIONAL AGENTS

  6. PROPOSED MECHANISMS OF INHALATION ANESTHETIC ACTION • General anesthesia is an altered physiologic state characterized by reversible loss of consciousness, analgesia of the entire body, amnesia, and to some degree muscle relaxation • Meyer-Overton Rule (Critical Volume Hypothesis) • Protein Receptor Hypothesis (Agent Specific Theory) • Microcrystaline Theory • Alteration in Neurotransmitter Availability

  7. MINIMUM ALVEOLAR CONCENTRATION • MAC defined as • MAC mirrors brain partial pressure, allows comparisons of potency between agents, and provides a standard for experimental evaluations • Patient specific • MAC %: • N2O • Halothane • Ethrane • Forane • Desflurane • Sevoflurane • Factors affecting MAC

  8. NITROUS OXIDE • Physical Properties • Effects on Organ Systems: • Cardiovascular • Respiratory • Cerebral • Neuromuscular • Renal • Hepatic • Gastrointestinal • Biotransformation and Toxicity • Contraindications • Drug Interactions

  9. HALOTHANE • Physical Properties • Effects on Organ Systems: • Cardiovascular • Respiratory • Cerebral • Neuromuscular • Renal • Hepatic • Biotransformation and Toxicity • Contraindications • Drug Interactions

  10. ETHRANE • Physical Properties • Effects on Organ Systems: • Cardiovascular • Respiratory • Cerebral • Neuromuscular • Renal • Hepatic • Biotransformation and Toxicity • Contraindications • Drug Interactions

  11. FORANE • Physical Properties • Effects on Organ Systems: • Cardiovascular • Respiratory • Cerebral • Neuromuscular • Renal • Hepatic • Biotransformation and Toxicity • Contraindications • Drug Interactions

  12. DESFLURANE • Physical Properties • Effects on Organ Systems: • Cardiovascular • Respiratory • Cerebral • Neuromuscular • Renal • Hepatic • Biotransformation and Toxicity • Contraindications • Drug Interactions

  13. SEVOFLURANE • Physical Properties • Effects on Organ Systems: • Cardiovascular • Respiratory • Cerebral • Neuromuscular • Renal • Hepatic • Biotransformation and Toxicity • Contraindications • Drug Interactions

  14. IDEAL INHALATIONAL ANESTHETIC • Rapid onset – rapid recovery • Easy to administer • Possess clear indication of anesthetic depth • No significant effect on organ systems • High margin of safety for all age groups • Inexpensive

  15. CLINCAL CASE STUDIES • 78 year old male presents to OR from ED diagnosed with a small bowel obstruction. PMH: CHF, CAD, and history of seizures 2 years prior to admission. • 26 year old female presents to OR for emergent cesarean section. General anesthesia is initiated due to fetal distress (bradycardia and acidosis). PMH: negative. • 47 year old male presents to OR for elective colon resection. PMH: CRFand arthritis. • 6 year old female presents to the OR for elective adenoidectomy and tonsillectomy. PMH: negative.

  16. REFERENCES • Morgan, G.E., Mikhail, M.S., and Murray, M.J. (2006). Clinical Anesthesiology. (4th ed.) New York, NY: McGraw-Hill. • Stoelting, R.K. (1999). Pharmacology & Physiology in Anesthetic Practice. (3rd ed.) Philadelphia, PA: J.B. Lippincott Company.

More Related